Health care stocks gained Wednesday afternoon, with the NYSE Health Care Index up 0.4% and the Health Care Select Sector SPDR Fund (XLV) adding 0.5%.
The iShares Biotechnology ETF (IBB) increased 0.4%.
In corporate news, Trinity Biotech (TRIB) shares jumped about 28% after it said Wednesday that it has received regulatory approval to begin offshore and outsourced manufacturing of its TrinScreen HIV rapid test.
Tharimmune (THAR) shares surged 103% after it said Wednesday that results from an analysis of its lead drug candidate TH104 showed that it could potentially be used as a countermeasure for military personnel and chemical incident responders exposed to high-potency opioids, including weaponized fentanyl.
CVS Health's (CVS) Caremark unit has been ordered to pay about $289.9 million in a whistleblower case involving Medicare fraud claims, according to a court ruling on Tuesday. CVS shares increased 0.2%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。